Morgan Stanley (NYSE:MS) Price Target Raised to $205.00 at BNP Paribas Exane

Key Points

• BNP Paribas Exane raised its price target to $205 from $195, keeping a "neutral" rating and implying roughly a 9.0% upside from the current share price.
• Morgan Stanley beat quarterly expectations, reporting $3.43 EPS versus $3.02 consensus and revenue of $20.58B (vs. $19.23B), with revenue up 16% year‑over‑year.
• Analyst sentiment is mixed: ten analysts rate the stock Buy and thirteen rate it Hold, giving an average rating of "Hold" and an average price target of $201.89.

Morgan Stanley (NYSE:MS - Get Free Report) had its price target upped by stock analysts at BNP Paribas Exane from $195.00 to $205.00 in a report released on Friday,MarketScreener reports. The brokerage currently has a "neutral" rating on the financial services provider's stock. BNP Paribas Exane's target price would indicate a potential upside of 9.01% from the stock's current price.

A number of other equities research analysts have also weighed in on the company. Jefferies Financial Group lowered Morgan Stanley from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 9th. Argus boosted their target price on Morgan Stanley from $210.00 to $225.00 and gave the company a "buy" rating in a research note on Thursday, April 16th. Citizens Jmp reissued a "market perform" rating on shares of Morgan Stanley in a research note on Thursday, April 16th. Weiss Ratings reissued a "buy (b-)" rating on shares of Morgan Stanley in a research note on Thursday, January 22nd. Finally, Bank of America boosted their target price on Morgan Stanley from $220.00 to $225.00 and gave the company a "buy" rating in a research note on Thursday, April 16th. Ten analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat, Morgan Stanley currently has an average rating of "Hold" and an average price target of $201.89.

Morgan Stanley Trading Down 0.3%

Shares of NYSE MS traded down $0.60 during midday trading on Friday, reaching $188.05. The company had a trading volume of 308,123 shares, compared to its average volume of 7,196,028. Morgan Stanley has a one year low of $112.03 and a one year high of $194.59. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 3.39. The firm's fifty day moving average price is $169.91 and its 200-day moving average price is $171.58. The stock has a market cap of $297.38 billion, a PE ratio of 17.04, a price-to-earnings-growth ratio of 1.44 and a beta of 1.19.

Morgan Stanley (NYSE:MS - Get Free Report) last released its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, beating analysts' consensus estimates of $3.02 by $0.41. Morgan Stanley had a return on equity of 17.89% and a net margin of 14.65%.The company had revenue of $20.58 billion during the quarter, compared to analyst estimates of $19.23 billion. During the same quarter in the previous year, the company posted $2.60 EPS. Morgan Stanley's revenue for the quarter was up 16.0% on a year-over-year basis. On average, equities research analysts anticipate that Morgan Stanley will post 11.8 earnings per share for the current year.

Insider Activity at Morgan Stanley

In related news, insider Daniel A. Simkowitz sold 32,968 shares of the business's stock in a transaction dated Friday, January 30th. The stock was sold at an average price of $182.61, for a total transaction of $6,020,286.48. Following the transaction, the insider owned 357,342 shares in the company, valued at $65,254,222.62. The trade was a 8.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Andrew M. Saperstein sold 51,668 shares of the business's stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $188.59, for a total value of $9,744,068.12. Following the transaction, the insider owned 282,142 shares in the company, valued at approximately $53,209,159.78. This represents a 15.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 110,444 shares of company stock worth $20,665,049 in the last 90 days. Company insiders own 0.17% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Farther Finance Advisors LLC lifted its position in Morgan Stanley by 40.1% in the 4th quarter. Farther Finance Advisors LLC now owns 29,744 shares of the financial services provider's stock valued at $5,281,000 after acquiring an additional 8,512 shares in the last quarter. Bahl & Gaynor Inc. lifted its holdings in shares of Morgan Stanley by 103.1% during the 3rd quarter. Bahl & Gaynor Inc. now owns 12,700 shares of the financial services provider's stock valued at $2,019,000 after buying an additional 6,448 shares during the period. Donaldson Capital Management LLC lifted its holdings in shares of Morgan Stanley by 2.0% during the 3rd quarter. Donaldson Capital Management LLC now owns 467,246 shares of the financial services provider's stock valued at $74,273,000 after buying an additional 9,056 shares during the period. ABN Amro Investment Solutions lifted its holdings in shares of Morgan Stanley by 52.6% during the 3rd quarter. ABN Amro Investment Solutions now owns 113,504 shares of the financial services provider's stock valued at $18,043,000 after buying an additional 39,104 shares during the period. Finally, A4 Wealth Advisors LLC bought a new position in shares of Morgan Stanley during the 3rd quarter valued at $855,000. Hedge funds and other institutional investors own 84.19% of the company's stock.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley's Investment Management launched a Stablecoin Reserves Portfolio (MSNXX) that lets stablecoin issuers park reserves in a Morgan Stanley money‑market fund (minimum $10M). This expands fee-bearing institutional product offerings in digital assets and positions MS as a trusted custodian/partner for crypto infrastructure. Morgan Stanley launches stablecoin offering through money market fund
• Positive Sentiment: Institutional crypto flows are benefiting Morgan Stanley’s asset-management franchise: the bank’s bitcoin ETF (MSBT) has seen meaningful early inflows and reports note a large institutional allocation (~$138M referenced in market coverage). That supports AUM growth and fee revenue. $138M Bitcoin Play Triggers Rally
• Neutral Sentiment: NZX accredited Morgan Stanley as a clearing participant for its derivatives market ahead of new S&P/NZX 20 futures — a niche expansion in derivatives clearing that broadens MS's institutional footprint but is unlikely to move near-term earnings materially. NZX Adds Morgan Stanley as Clearing Participant
• Neutral Sentiment: Analyst/market commentary (Zacks, MarketBeat pieces) highlight Morgan Stanley’s capital‑markets strength and wealth‑management push — favorable for longer‑term growth — while noting execution risks; these notes help sentiment but are not fresh company disclosures. The Zacks Analyst Blog UnitedHealth, Morgan Stanley, RTX, Homes Group and Motorsport
• Negative Sentiment: Macro and internal notes raise caution: Morgan Stanley commentary on GDP/outlook and analyst mentions of rising expenses and trading volatility suggest pressure on trading revenues and margins if market activity softens — a headwind for short‑term profitability. Morgan Stanley drops stunning take on GDP outlook

About Morgan Stanley

Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.

The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.